Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

132.00p
   
  • Change Today:
      4.50p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 56,663
  • Market Cap: £111.90m
  • RiskGrade: 196
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
71.57% above the market average71.57% above the market average71.57% above the market average71.57% above the market average71.57% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
14.37% above the market average14.37% above the market average14.37% above the market average14.37% above the market average14.37% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average
Price Book Ratio
57.76% below the market average57.76% below the market average57.76% below the market average57.76% below the market average57.76% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
3.05% above the market average3.05% above the market average3.05% above the market average3.05% above the market average3.05% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average
Price Chg 3m
41.47% below the market average41.47% below the market average41.47% below the market average41.47% below the market average41.47% below the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Momentum 20
26.51% above the market average26.51% above the market average26.51% above the market average26.51% above the market average26.51% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
49.75% below the market average49.75% below the market average49.75% below the market average49.75% below the market average49.75% below the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
65.76% below the market average65.76% below the market average65.76% below the market average65.76% below the market average65.76% below the market average
35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
10.45% below the market average10.45% below the market average10.45% below the market average10.45% below the market average10.45% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average
Operating Profit Loss
59.79% below the market average59.79% below the market average59.79% below the market average59.79% below the market average59.79% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.30% above the market average3.30% above the market average3.30% above the market average3.30% above the market average3.30% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average
Cash
15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
17.73% above the market average17.73% above the market average17.73% above the market average17.73% above the market average17.73% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average
Buys 1y
13.68% below the market average13.68% below the market average13.68% below the market average13.68% below the market average13.68% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 132.00p
Change Today 4.50p
% Change 3.53 %
52 Week High 150.00
52 Week Low 108.00
Volume 56,663
Shares Issued 84.77m
Market Cap £111.90m
Beta 0.01
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.34% below the market average32.34% below the market average32.34% below the market average32.34% below the market average32.34% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Price Trend
73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
Income Not Available
Growth
39.08% above the market average39.08% above the market average39.08% above the market average39.08% above the market average39.08% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 19-May-2025

Time Volume / Share Price
16:24 14 @ 133.90p
16:21 1,187 @ 133.90p
16:09 3,965 @ 131.50p
16:07 1 @ 134.00p
15:49 6,506 @ 133.50p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page